We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13B
AUM Growth
+$984M
Cap. Flow
+$180M
Cap. Flow %
1.38%
Top 10 Hldgs %
38.14%
Holding
1,449
New
52
Increased
710
Reduced
341
Closed
132

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$287M
2
DLR icon
Digital Realty Trust
DLR
+$150M
3
HR icon
Healthcare Realty
HR
+$110M
4
WELL icon
Welltower
WELL
+$106M
5
O icon
Realty Income
O
+$88.1M

Sector Composition

Rank Sector Weight
1 Real Estate 57.53%
2 Technology 9.67%
3 Healthcare 4.73%
4 Financials 4.38%
5 Consumer Discretionary 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTHX
1276
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1K ﹤0.01%
145
HLTH
1277
DELISTED
Cue Health Inc. Common Stock
HLTH
$1K ﹤0.01%
+601
New +$1.9K
ALPN
1278
DELISTED
Alpine Immune Sciences Inc
ALPN
$1K ﹤0.01%
85
NGM
1279
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$1K ﹤0.01%
265
KNTE
1280
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$1K ﹤0.01%
127
NSTG
1281
DELISTED
NanoString Technologies, Inc.
NSTG
$1K ﹤0.01%
156
CNCE
1282
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$1K ﹤0.01%
+193
New +$1.01K
ACIU icon
1283
AC Immune
ACIU
$236M
-158
Closed
ADEA icon
1284
Adeia
ADEA
$2.77B
-19,282
Closed -$19K
ADVM
1285
DELISTED
Adverum Biotechnologies
ADVM
-18
Closed
AKAM icon
1286
PUT
Akamai
AKAM
$16.3B
-500
Closed -$25K
AKBA icon
1287
Akebia Therapeutics
AKBA
$341M
-316
Closed
ALGS icon
1288
Aligos Therapeutics
ALGS
$26.3M
-5
Closed
ALNY icon
1289
PUT
Alnylam Pharmaceuticals
ALNY
$38.5B
-100
Closed -$93K
AMC icon
1290
AMC Entertainment Holdings
AMC
$2.38B
-2,726
Closed -$190K
APLT
1291
DELISTED
Applied Therapeutics
APLT
-42
Closed
APP icon
1292
Applovin
APP
$140B
-6,262
Closed -$122K
LONA
1293
LeonaBio Inc
LONA
$65.5M
-11
Closed
ATHM icon
1294
Autohome
ATHM
$2.65B
-64,487
Closed -$1.85M
AUTL
1295
Autolus Therapeutics
AUTL
$386M
-74
Closed
JBIO
1296
Jade Biosciences
JBIO
$1.2B
-2
Closed -$1K
BAND
1297
CALL
Bandwidth Inc
BAND
$1.67B
-50
Closed -$1K
BDTX icon
1298
Black Diamond Therapeutics
BDTX
$101M
-106
Closed
BVS icon
1299
Bioventus
BVS
$895M
-173
Closed -$1K
CABA icon
1300
Cabaletta Bio
CABA
$445M
-45
Closed

Similar funds

Daiwa Securities Group's Q4 2022 Portfolio in Review

As of Q4 2022, Daiwa Securities Group held 1,449 positions worth $13B, up 8.2% from $12B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q4 2022 filing shows 52 new, 710 increased, 341 reduced and 132 closed positions. Its largest new stake was Atlassian: 9,371 shares worth $1.21M. The largest sale was Duke Realty Corp., an estimated $310M.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q4 2022 buy was Atlassian: 9,371 shares worth $1.21M.
  • Daiwa Securities Group added most to Prologis in Q4 2022, an estimated $287M increase.
  • Daiwa Securities Group's biggest Q4 2022 reduction was Simon Property Group, cutting an estimated $93.4M.
  • Daiwa Securities Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $310M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13B portfolio in Q4 2022.
  • Daiwa Securities Group opened 52 new positions and closed 132 in Q4 2022.
  • Daiwa Securities Group's portfolio value rose 8.2% quarter-over-quarter to $13B.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.